This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Martuza, R.L. Act locally, think globally. Nature Med. 12, 1323 (1997).
Maclean, A.R. et al. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence related sequences in Glasgow strain 17+ between immediate eariy gene 1 and the ‘a’ sequence. J. Gen. Virol. 72,631–639 (1991).
Kesari, S. et al. A mutant herpes simplex virus replicates in brain tumours but not in neurons derived from a human embryonal carcinoma cell line. Lab. Invest. 73, 636-648 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rampling, R., Cruickshank, G., Maclean, A. et al. Therapeutic replication-competent herpes virus. Nat Med 4, 133 (1998). https://doi.org/10.1038/nm0298-133c
Issue date:
DOI: https://doi.org/10.1038/nm0298-133c
This article is cited by
-
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
Gene Therapy (2000)
-
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
Nature Medicine (1999)
-
HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and Applications
Neoplasia (1999)
-
Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine
Gene Therapy (1999)